![David Fisher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Fisher
Directeur/Membre du Conseil chez
Australian Biomedical Fund No. 1 Ltd.
Profil
David M.
Fisher is currently a Director at Australian Biotechnology & Healthcare Fund No.
3 Ltd., Australian Biomedical Fund No.
1 Ltd., and Australian Biomedical Fund No.
2 Ltd. He is a Venture Partner at Brandon Capital Partners Pty Ltd. since 2006 and a Member of AusBiotech Ltd. Formerly, Dr. Fisher was Chief Executive Officer at Arana Therapeutics Ltd., GI Therapies Pty Ltd., and Cephalon LLC.
He served as Non-Executive Director at Aeris Environmental Ltd. from 2013 to 2014, and also held Non-Executive Director roles at Signostics Ltd. and Director at Global Kinetics Pty Ltd. From 2012 to 2024, he was an Independent Non-Executive Director at Nanosonics Ltd. Education includes undergraduate and doctorate degrees from The University of Sydney.
Postes actifs de David Fisher
| Sociétés | Poste | Début |
|---|---|---|
Australian Biomedical Fund No. 1 Ltd.
 Australian Biomedical Fund No. 1 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Directeur/Membre du Conseil | - |
Australian Biomedical Fund No. 2 Ltd.
 Australian Biomedical Fund No. 2 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Directeur/Membre du Conseil | - |
Australian Biotechnology & Healthcare Fund No. 3 Ltd.
 Australian Biotechnology & Healthcare Fund No. 3 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Directeur/Membre du Conseil | - |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Corporate Officer/Principal | - |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 01/09/2006 |
Anciens postes connus de David Fisher
| Sociétés | Poste | Fin |
|---|---|---|
| NANOSONICS LIMITED | Directeur/Membre du Conseil | 12/11/2024 |
| AERIS ENVIRONMENTAL LTD | President | 29/03/2013 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur Général | - |
GI Therapies Pty Ltd.
 GI Therapies Pty Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices for the treatment of chronic constipation | Directeur Général | - |
| ░░░░░░ ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de David Fisher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Nanosonics Ltd.
 Nanosonics Ltd. Medical SpecialtiesHealth Technology Engages in the research, development and commercialization of infection control and decontamination products and related technologies | Health Technology |
Arana Therapeutics Ltd.
 Arana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals; researches medical diagnostic products | Health Technology |
Aeris Environmental Ltd.
 Aeris Environmental Ltd. Household/Personal CareConsumer Non-Durables Manufactures and distributes cleaning products | Consumer Non-Durables |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Biotechnology & Healthcare Fund No. 3 Ltd.
Australian Biotechnology & Healthcare Fund No. 3 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Australian Biomedical Fund No. 1 Ltd.
Australian Biomedical Fund No. 1 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Australian Biomedical Fund No. 2 Ltd.
Australian Biomedical Fund No. 2 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Signostics Ltd.
 Signostics Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Global Kinetics Pty Ltd.
 Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices for neurology and provides related services | Health Technology |
GI Therapies Pty Ltd.
GI Therapies Pty Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices for the treatment of chronic constipation | Health Technology |
